StockData
Lisata Therapeutics, Inc. logo

Lisata Therapeutics, Inc. (LSTA) stock

LSTANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$0.98−0.06 (-5.76%)

Close on Nov 18, 2026Market cap $8.83MP/E –Yield –

Lisata Therapeutics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Lisata Therapeutics's total debt was $0 at Dec 31, 2017. For fiscal 2017 it was $0, down 100.0% from the year before. The highest annual figure on record is $15.00M in fiscal 2014.

Annual total debt

PeriodPeriod endValueChange
FY2017Dec 31, 2017$0-100.0%
FY2016Dec 31, 2016$5.65M-62.3%
FY2015Dec 31, 2015$15.00M0.0%
FY2014Dec 31, 2014$15.00M–
FY2013Dec 31, 2013$0-100.0%
FY2012Dec 31, 2012$171.53K–
FY2011Dec 31, 2011$0–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2017Dec 31, 2017$0-100.0%
Q3 FY2017Sep 30, 2017$0-100.0%
Q2 FY2017Jun 30, 2017$0–
Q1 FY2017Mar 31, 2017$4.89M–
Q4 FY2016Dec 31, 2016$5.65M–
Q3 FY2016Sep 30, 2016$5.65M–

More Lisata Therapeutics figures

See a number that looks wrong?